Your browser doesn't support javascript.
loading
One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape.
Rymer, Jennifer A; Kirtane, Ajay J; Farb, Andrew; Malone, Misti; Jaff, Michael R; Seward, Kirk; Stephens, Dan; Barakat, Mark K; Krucoff, Mitchell W.
Afiliação
  • Rymer JA; Duke University School of Medicine, Durham, NC, United States of America; Duke Clinical Research Institute, Durham, NC, United States of America. Electronic address: jennifer.rymer@duke.edu.
  • Kirtane AJ; Columbia University Irving Medical Center, New York, United States of America.
  • Farb A; US Food and Drug Administration, Silver Spring, MD, United States of America.
  • Malone M; US Food and Drug Administration, Silver Spring, MD, United States of America.
  • Jaff MR; Boston Scientific Corporation, Marlborough, MA, United States of America.
  • Seward K; Mercator MedSystems, Inc., Emeryvlle, CA, United States of America.
  • Stephens D; Boston Scientific Corporation, Marlborough, MA, United States of America.
  • Barakat MK; CeloNova BioSciences, San Antonio, TX, United States of America.
  • Krucoff MW; Duke University School of Medicine, Durham, NC, United States of America; Duke Clinical Research Institute, Durham, NC, United States of America.
Cardiovasc Revasc Med ; 45: 67-73, 2022 12.
Article em En | MEDLINE | ID: mdl-35953406

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article